| Primary |
| Product Used For Unknown Indication |
25.6% |
| Parkinson's Disease |
18.6% |
| Parkinsonism |
7.0% |
| Hypertension |
4.7% |
| Multiple Sclerosis |
4.7% |
| Restless Legs Syndrome |
4.7% |
| Tremor |
4.7% |
| Arthralgia |
2.3% |
| Back Pain |
2.3% |
| Bacterial Disease Carrier |
2.3% |
| Brain Injury |
2.3% |
| Chronic Fatigue Syndrome |
2.3% |
| Dementia |
2.3% |
| Depressed Level Of Consciousness |
2.3% |
| Diabetes Mellitus |
2.3% |
| Extrapyramidal Symptoms |
2.3% |
| Fatigue |
2.3% |
| Frontotemporal Dementia |
2.3% |
| Gait Disturbance |
2.3% |
| Hyperthyroidism |
2.3% |
|
| Corneal Oedema |
9.1% |
| Visual Acuity Reduced |
9.1% |
| Alopecia |
4.5% |
| Dehydration |
4.5% |
| Drug Ineffective For Unapproved Indication |
4.5% |
| Fall |
4.5% |
| Hallucination |
4.5% |
| Hallucination, Auditory |
4.5% |
| Hallucination, Visual |
4.5% |
| Hallucinations, Mixed |
4.5% |
| Hypoaesthesia |
4.5% |
| Oedema |
4.5% |
| On And Off Phenomenon |
4.5% |
| Oropharyngeal Pain |
4.5% |
| Pulmonary Embolism |
4.5% |
| Sinus Tachycardia |
4.5% |
| Somnolence |
4.5% |
| Tangentiality |
4.5% |
| Unresponsive To Stimuli |
4.5% |
| Ventricular Tachycardia |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
22.9% |
| Parkinson's Disease |
17.8% |
| Delirium |
10.2% |
| Vascular Parkinsonism |
10.2% |
| Depression |
8.5% |
| Influenza |
6.8% |
| Parkinsonism |
5.1% |
| Hypertension |
4.2% |
| Neuroleptic Malignant Syndrome |
2.5% |
| Diabetes Mellitus |
1.7% |
| Gastric Ulcer |
1.7% |
| Malignant Melanoma |
1.7% |
| Back Pain |
0.8% |
| Dementia |
0.8% |
| Fatigue |
0.8% |
| Glaucoma |
0.8% |
| Hyperlipidaemia |
0.8% |
| Influenza Immunisation |
0.8% |
| Major Depression |
0.8% |
| Multiple Sclerosis |
0.8% |
|
| Jaundice |
13.8% |
| Off Label Use |
10.3% |
| Alopecia |
6.9% |
| Brugada Syndrome |
6.9% |
| Hallucinations, Mixed |
6.9% |
| Myocardial Infarction |
6.9% |
| Adverse Drug Reaction |
3.4% |
| Confusional State |
3.4% |
| Corneal Oedema |
3.4% |
| Cyanosis |
3.4% |
| Dehydration |
3.4% |
| Electrocardiogram Qt Prolonged |
3.4% |
| Hallucination |
3.4% |
| Hepatitis Fulminant |
3.4% |
| No Adverse Event |
3.4% |
| Renal Failure Chronic |
3.4% |
| Serotonin Syndrome |
3.4% |
| Speech Disorder |
3.4% |
| Syncope |
3.4% |
| Vascular Insufficiency |
3.4% |
|
| Concomitant |
| Parkinson's Disease |
28.2% |
| Drug Use For Unknown Indication |
16.6% |
| Hypertension |
12.4% |
| Pneumonia |
7.0% |
| Arthritis |
3.9% |
| Multiple Sclerosis |
3.7% |
| Pain |
3.7% |
| Product Used For Unknown Indication |
3.1% |
| Dyspepsia |
2.6% |
| Parkinsonism |
2.6% |
| Depression |
2.0% |
| Infection |
2.0% |
| Bacterial Infection |
1.7% |
| Fatigue |
1.7% |
| Hormone Therapy |
1.7% |
| Delirium |
1.5% |
| Prophylaxis |
1.5% |
| Dementia |
1.3% |
| Dyspnoea |
1.3% |
| Hepatitis C |
1.3% |
|
| Renal Failure Acute |
11.4% |
| Parkinson's Disease |
10.0% |
| Musculoskeletal Stiffness |
7.1% |
| Oedema Peripheral |
5.7% |
| Drug Ineffective |
4.3% |
| Nausea |
4.3% |
| Neuroleptic Malignant Syndrome |
4.3% |
| Pneumonia Aspiration |
4.3% |
| Somnolence |
4.3% |
| Subarachnoid Haemorrhage |
4.3% |
| Swelling |
4.3% |
| Urinary Tract Infection |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Visual Acuity Reduced |
4.3% |
| Visual Impairment |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
| Yellow Skin |
4.3% |
| Erythema |
2.9% |
| Hallucination |
2.9% |
|
| Interacting |
| Parkinson's Disease |
50.0% |
| Parkinsonian Gait |
50.0% |
|
|
